{"url_path":"/sec/pure/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-03-17","source_url":"https://www.sec.gov/Archives/edgar/data/1006028/0001493152-26-010385-index.html","accession_number":"0001493152-26-010385","cik":"0001006028","ticker":"PURE","issuer_name":"PURE BIOSCIENCE, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006028/0001493152-26-010385-index.html","primary_entity_key":"0001006028","primary_entity_name":"PURE BIOSCIENCE, INC."},"word_count":462,"has_tables":true,"body_markdown":"**Item\n6. Exhibits**\n\n \n\nThe\nfollowing Exhibits are filed as part of this report pursuant to Item 601 of Regulation S-K:\n\n \n\n3.1\n[Certificate of Incorporation of PURE Bioscience, Inc. (incorporated by reference to Exhibit 3.1 of the Annual Report on Form 10-K filed with the SEC on October 29, 2012)](https://www.sec.gov/Archives/edgar/data/1006028/000107997312000838/ex3x1.htm)\n\n \n \n\n3.1.1\n[Certificate of Amendment to Certificate of Incorporation of PURE Bioscience, Inc. (incorporated by reference to Exhibit 3.1.1 of the Annual Report on Form 10-K filed with the SEC on October 29, 2012)](https://www.sec.gov/Archives/edgar/data/1006028/000107997312000838/ex3x1x1.htm)\n\n \n \n\n3.1.2\n[Certificate of Amendment to Certificate of Incorporation of PURE Bioscience, Inc. (incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed with the SEC on May 19, 2021).](https://www.sec.gov/Archives/edgar/data/1006028/000149315221012254/ex3-1.htm)\n\n \n \n\n3.2\n[Bylaws of PURE Bioscience, Inc. (incorporated by reference to Exhibit 3.2 to the Annual Report on Form 10-K, filed with the SEC on October 29, 2012)](https://www.sec.gov/Archives/edgar/data/1006028/000107997312000838/ex3x2.htm)\n\n \n \n\n3.2.1\n[Amendment to the Bylaws of PURE Bioscience, Inc. (incorporated by reference to Exhibit 3.2.1 to the Annual Report on Form 10-K, filed with the SEC on October 29, 2012)](https://www.sec.gov/Archives/edgar/data/1006028/000107997312000838/ex3x2x1.htm)\n\n \n \n\n31.1\n*\n[Certification of Chief Executive Officer, pursuant to Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-1.htm)\n\n \n \n\n31.2\n*\n[Certification of Principal Financial Officer, pursuant to Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-2.htm)\n\n \n \n\n32.1\n*\n[Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-1.htm)\n\n \n \n\n32.2\n*\n[Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-2.htm)\n\n \n \n\n101\n*\nThe\nfollowing materials from the Company’s Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2026, formatted\nin iXBRL (Inline eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets at January 31, 2026 and July\n31, 2025; (ii) Condensed Consolidated Statements of Operations for the three and six months ended January 31, 2026 and 2025; (iii)\nCondensed Consolidated Statements of Stockholders’ equity for the three and six months ended January 31, 2026 and 2025 ;(iv)\nCondensed Consolidated Statements of Cash Flows for the six months ended January 31, 2026 and 2025; and (v) Notes to Condensed Consolidated\nFinancial Statements.\n\n \n \n\n104*\nCover\nPage Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\n\n \n\n*\nFiled\nherewith.\n\n \n\n25\n\n \n\n \n\n**Signatures**\n\n \n\nPursuant\nto the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the\nundersigned thereunto duly authorized.\n\n \n\n \n**PURE\nBIOSCIENCE, INC.**\n\n \n \n \n\nDate:\nMarch 16, 2026\nBy: \n*/s/\nROBERT F. BARTLETT*\n\n \n \n\nRobert\nF. Bartlett, Chief Executive Officer\n\n(Principal\nExecutive Officer)\n\n \n \n \n\nDate:\nMarch 16, 2026\nBy:\n*/s/\nMARK S. ELLIOTT*\n\n \n \nMark\nS. Elliott, Vice President, Finance\n\n \n \n(Principal\nFinancial and Accounting Officer)\n\n \n\n26"}